Andrew Huberman
Andrew Huberman
@hubermanlab·7.5M subscribers·510 videos

The Science of Psychedelics for Mental Health | Dr. Robin Carhart-Harris

Posted

May 22, 2023

Views

778,978

Likes

12,998

Comments

1,603

Engagement

1.87%

Search the Record

Indexed

Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.

Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.

Try a name, a topic, or a quoted line

Chapters

Segments

YouTube Description

as posted by the channel

In this episode, my guest is Robin Carhart-Harris, PhD, distinguished professor of neurology and psychiatry at the University of California, San Francisco. He is one of the leading researchers studying how psychedelics such as psilocybin, LSD and DMT can change the human brain and, in doing so, be used to successfully treat various mental health challenges such as major depression, anorexia, obsessive-compulsive disorder (OCD) and addiction. He explains how psilocybin induces sustained changes in adaptive brain wiring and cognition.

We discuss the key components of safe and effective psychedelic journeys, the role of hallucinations, the use of eye masks to encourage people to “go internal” and music, as well as what effective therapist support consists of before, during and after the session (also known as integration). We explore microdosing versus macrodosing and how researchers control for placebo effects in psychedelic research. We also examine the current legal landscape surrounding psychedelic therapies. Psychedelic therapies are fast emerging as powerful and soon-to-be mainstream treatments for mental health disorders, but they are not without risk. As such, this episode ought to be of use to anyone interested in brain plasticity, mental health, psychology or neuroscience.

Thank you to our sponsors

AG1 (Athletic Greens)

Eight Sleep

The Brain Body Contract

Huberman Lab Social & Website

Dr. Robin Carhart-Harris

Academic Profile

Publications

Support USCF Psychedelic Research Fund

UCSF Clinical Trials Enrollment

Articles

Selfblinding citizen science to explore psychedelic microdosing

Trial of Psilocybin versus Escitalopram for Depression

Pivotal mental states

Increased global integration in the brain after psilocybin therapy for depression

Structurebased discovery of nonhallucinogenic psychedelic analogs

SelfMedication for Chronic Pain Using Classic PsychedelicsA Qualitative Investigation to Inform Future Research

MDMAassisted therapy for severe PTSDa randomized, doubleblind, placebocontrolled phase 3 study

Timestamps

Title Card Photo CreditMike Blabac

Guests & Subjects Covered

Robin Carhart-Harris PhDCalifornia San Francisco HeDepression PivotalInform Future Research MDMA-assistedWord Psychedelics Pharmacology PsychedelicsPsychedelic Effects SSRIs PsilocybinDepression Long-Term Effects ConnectivityAnorexia Integration Phase

Sentinel Indexing in Progress

Metadata and chapters are available. Claim extraction for this episode is pending.

All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.